ZA945425B - 2-amino-4-phenyl-4-oxo-butyric acid derivatives - Google Patents

2-amino-4-phenyl-4-oxo-butyric acid derivatives

Info

Publication number
ZA945425B
ZA945425B ZA945425A ZA945425A ZA945425B ZA 945425 B ZA945425 B ZA 945425B ZA 945425 A ZA945425 A ZA 945425A ZA 945425 A ZA945425 A ZA 945425A ZA 945425 B ZA945425 B ZA 945425B
Authority
ZA
South Africa
Prior art keywords
oxo
phenyl
amino
butyric acid
acid derivatives
Prior art date
Application number
ZA945425A
Other languages
English (en)
Inventor
Mario Varasi
Antonio Giordani
Carmela Speciale
Massimo Cini
Alberto Bianchetti
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of ZA945425B publication Critical patent/ZA945425B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA945425A 1993-07-23 1994-07-22 2-amino-4-phenyl-4-oxo-butyric acid derivatives ZA945425B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT93MI001649A IT1265101B1 (it) 1993-07-23 1993-07-23 Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico

Publications (1)

Publication Number Publication Date
ZA945425B true ZA945425B (en) 1995-03-01

Family

ID=11366678

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA945425A ZA945425B (en) 1993-07-23 1994-07-22 2-amino-4-phenyl-4-oxo-butyric acid derivatives

Country Status (21)

Country Link
US (1) US20010008947A1 (sv)
EP (1) EP0662948B1 (sv)
JP (1) JPH08501805A (sv)
KR (1) KR950703517A (sv)
CN (1) CN1112786A (sv)
AT (1) ATE171935T1 (sv)
AU (1) AU678273B2 (sv)
CA (1) CA2144521A1 (sv)
DE (1) DE69413789T2 (sv)
DK (1) DK0662948T3 (sv)
ES (1) ES2123801T3 (sv)
FI (1) FI951298A0 (sv)
HU (1) HUT70478A (sv)
IL (1) IL110365A (sv)
IT (1) IT1265101B1 (sv)
NZ (1) NZ268896A (sv)
PL (1) PL179857B1 (sv)
RU (1) RU2139850C1 (sv)
TW (1) TW268937B (sv)
WO (1) WO1995003271A1 (sv)
ZA (1) ZA945425B (sv)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5519055A (en) * 1993-08-06 1996-05-21 University Of Maryland At Baltimore Substituted kynurenines and process for their preparation
US5786508A (en) * 1994-07-15 1998-07-28 Pharmacia & Upjohn S.P.A. Substituted kynurenines and process for their preparation
GB9521486D0 (en) * 1995-10-20 1995-12-20 Pharmacia Spa Fluoro-substituted benzoylpropionic acid derivatives
GB9615441D0 (en) * 1996-07-23 1996-09-04 Pharmacia Spa Benzoylpropionic acid ester derivatives
AU3729397A (en) * 1996-08-16 1998-03-06 Warner-Lambert Company Butyric acid matrix metalloproteinase inhibitors
GB9618349D0 (en) * 1996-09-03 1996-10-16 Pharmacia Spa N-substituted 2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity
GB9716103D0 (en) * 1997-07-30 1997-10-01 Pharmacia & Upjohn Spa Condensed heterocyclic compounds
GB9725055D0 (en) * 1997-11-26 1998-01-28 Pharmacia & Upjohn Spa 1,3,4-thiadiazoles compounds
GB9725141D0 (en) * 1997-11-27 1998-01-28 Pharmacia & Upjohn Spa Benzenesulfonamide compounds
NZ506260A (en) * 1998-02-23 2003-05-30 Univ South Alabama Indole-3-propionic acids, salts and esters thereof used as medicaments
US6783965B1 (en) * 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
WO2000027798A1 (en) * 1998-11-11 2000-05-18 Novartis Ag Production of 2-amino-2-[2-(4-c2-20-alkyl-phenyl)ethyl]propane-1,3-diols
CN1144779C (zh) * 1999-03-11 2004-04-07 杭州中美华东制药有限公司 制备2-[2-(4-烷基苯基)-乙基]-2-氨基-丙二醇的方法以及其中制得的中间产物
JP4711621B2 (ja) * 2001-06-12 2011-06-29 ウェルスタット セラピューティクス コーポレイション 代謝障害治療用化合物
FR2827045B1 (fr) * 2001-07-05 2007-08-10 Univ Pasteur Methodes et compositions pour la selection et le developpement de nouveaux agents pharmacologiques ou de nouveaux medicaments
FR2827859B1 (fr) 2001-07-30 2005-09-23 Lipha Derives 4-(arylthio) - ou 4-(heteroarylthio) -butyrique dans la preparation de medicaments destines au traitement du diabete
CN1330774C (zh) * 2002-03-01 2007-08-08 国家人类基因组南方研究中心 犬尿氨酸水解酶多态性及其用途
ITMI20041626A1 (it) * 2004-08-06 2004-11-06 Roberto Pellicciari Inibitori della chinurenina-ammino-trasferasi
CN1309702C (zh) * 2005-10-28 2007-04-11 中国科学院上海有机化学研究所 犬尿氨酸酶的特异性抑制剂l－邻甲氧基苯甲酰基丙氨酸的合成方法
BRPI0908727A2 (pt) 2008-03-19 2015-07-28 Novartis Ag Processo para preparar 2-amino-2-[2-(4-c3-c21-alquil-fenil)etil] propano-1,3-dióis
RU2727573C2 (ru) * 2014-09-26 2020-07-22 Ти Юниверсити Оф Бритиш Коламбиа Комбинация кинуренина и антигенпредставляющие клетки (apc) в качестве терапевтических средств и способ их применения в иммуномодуляции

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU643365B2 (en) * 1991-02-28 1993-11-11 Aventisub Ii Inc. NMDA antagonists
US5516936A (en) * 1991-04-18 1996-05-14 University Of Georgia Research Foundation, Inc. Inhibitors of kynureninase
US5495044A (en) * 1991-04-18 1996-02-27 University Of Georgia Research Foundation, Inc. Inhibitors of kynureninase
GB9325360D0 (en) * 1993-12-10 1994-02-16 Univ Bristol Organic compounds

Also Published As

Publication number Publication date
PL179857B1 (pl) 2000-11-30
DE69413789D1 (de) 1998-11-12
NZ268896A (en) 1997-01-29
EP0662948B1 (en) 1998-10-07
HUT70478A (en) 1995-10-30
AU678273B2 (en) 1997-05-22
IL110365A (en) 1998-06-15
CN1112786A (zh) 1995-11-29
DK0662948T3 (da) 1999-06-21
IL110365A0 (en) 1994-10-21
AU7228594A (en) 1995-02-20
IT1265101B1 (it) 1996-10-30
RU2139850C1 (ru) 1999-10-20
US20010008947A1 (en) 2001-07-19
ES2123801T3 (es) 1999-01-16
EP0662948A1 (en) 1995-07-19
FI951298A (sv) 1995-03-20
KR950703517A (ko) 1995-09-20
DE69413789T2 (de) 1999-05-06
WO1995003271A1 (en) 1995-02-02
PL308142A1 (en) 1995-07-24
RU95111308A (ru) 1996-12-27
ATE171935T1 (de) 1998-10-15
ITMI931649A1 (it) 1995-01-23
CA2144521A1 (en) 1995-02-02
FI951298A0 (sv) 1995-03-20
JPH08501805A (ja) 1996-02-27
ITMI931649A0 (it) 1993-07-23
TW268937B (sv) 1996-01-21
HU9501146D0 (en) 1995-06-28

Similar Documents

Publication Publication Date Title
TW268937B (sv)
BG101841A (en) Cellular adhesion inhibitors
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
IL111078A0 (en) Inhibitors of beta-amyloid protein production
GB0129260D0 (en) Pharmaceutical compositions and their uses
EP0374440A3 (en) Inhibitors of lysyl oxidase
IL123002A0 (en) 1-Phenyl-2- phenylacetoxy- ethanone derivatives
ZA943744B (en) Therapeutic substituted guanidines
EP1449834A3 (en) Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
EP0793660A4 (en) 2-SUBSTITUTED 1,2,5-THIADIAZOLIDIN-3-ON-1,1-DIOXIDES, COMPOSITION AND THEIR USE
BG102106A (en) Phermaceutical composition containing proteinase inhibitor and monoglyceride
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
WO1996022305A3 (en) Modified peptides
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
AU7812794A (en) Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
DK0719276T3 (da) Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold deraf
ES2065855A1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
MX9704035A (es) 1,1-dioxidos de 2-(fosfiniloximetil)-1,2,5-tiadiazolidin-3-ona substituidos y composiciones y metodo de uso de los mismos.
MX9704036A (es) 1,1-dioxidos y composiciones de 2-(2,3,5,6-tetrafluoro-4-piridil)-1,2,5-thiadizaolidin-3-ona y metodo de uso.
ES2058025A1 (es) Aplicacion del acido fitico y/o sus fitatos en los estados patologicos y prepatologicos derivados de la litiasis renal oxalocalcica idiopatica.
IL119421A0 (en) Pharmaceutical compositions for the treatment of arrhythmia